Gradient Investments LLC increased its stake in shares of Mcdonald’s Corp (NYSE:MCD) by 8.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,459 shares of the fast-food giant’s stock after acquiring an additional 4,689 shares during the period. Gradient Investments LLC’s holdings in Mcdonald’s were worth $9,160,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of MCD. Rainier Group Investment Advisory LLC acquired....More>>>
As a popular bet on market calm on Wall Street imploded, capsizing mom-and-pop investors and institutional investors alike on Monday, calls for stronger disclosures of the dangers inherent in some Wall Street products have intensified.
The VelocityShares Daily Inverse VIX Short Term ETN
A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business at a fair price than to buy a mediocre business at low price. We think that Nike is a great business at a fair price. We have been waiting for Nike’s price to come down for a long time and....More>>>
Zacks Investment Research upgraded shares of Johnson Matthey (OTCMKTS:JMPLY) from a sell rating to a hold rating in a report published on Tuesday.
According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical....More>>>
Swiss National Bank lifted its position in CONMED Co. (NASDAQ:CNMD) by 5.0% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 43,800 shares of the medical technology company’s stock after acquiring an additional 2,100 shares during the period. Swiss National Bank’s holdings in CONMED were worth $2,774,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Pinebridge Investments L.P. grew its stake in shares of CONMED by 72.7% in the fourth quarter. Pinebridge Investments....More>>>